查看购物车
  • Traditional Chinese
  • English
  • Japanese
全球牙科软组织再生市场按产品类型、应用、最终用户和地区划分－预测至2030年
市场调查报告书
商品编码
1869549

全球牙科软组织再生市场按产品类型、应用、最终用户和地区划分－预测至2030年

Dental Soft-tissue Regeneration Market by Product Type (Autografts, Synthetic Biomaterials, Collagen-based Membranes), Application (Implantology, Periodontology), End User (Dental Hospitals, DSO's & Independent Clinics), Region - Global Forecast to 2030
出版日期: | 出版商: MarketsandMarkets | 英文 227 Pages | 订单完成后即时交付

价格

预计牙科软组织再生市场将从 2025 年的 3.8 亿美元成长到 2030 年的 5.3 亿美元，在此期间的复合年增长率为 6.8%。

该市场显着增长归因于多种因素，例如牙周疾病发病率上升、口腔卫生意识增强以及美容牙科的日益普及。此外，发展中地区医疗基础建设的改善也推动了对牙科治疗及相关产品的需求。

调查范围
调查期 2024-2030
基准年 2024
预测期 2024-2030
目标单元 金额（十亿美元）
部分 按产品类型、应用程式、最终用户和地区划分
目标区域 北美、欧洲、亚太地区、拉丁美洲、中东和非洲以及海湾合作委员会国家

此外，组织工程生物材料的进步也在扩大市场方面发挥关键作用。

牙科软组织再生市场-IMG1

根据产品类型，胶原蛋白基膜预计将在牙科软组织再生市场占据主导地位，这主要归因于多种因素。胶原蛋白基膜可作为屏障引导组织生长，并支持牙周组织和植入相关缺损的癒合。此外，这些膜能够与周围组织整合，促进新结缔组织的生长。再生生医材料的创新也推动了该市场的成长。

由于人口老化、口腔卫生意识增强以及对美观牙科治疗需求不断增长等因素，植入领域预计将占据牙科软组织再生市场最大的份额。胶原蛋白蛋白膜、软组织移植片和先进的生物活性材料等产品正被越来越多地用于促进植入周围软组织的癒合。此外，软组织再生解决方案的创新以及人们对牙科美学的日益关注也进一步推动了牙科软组织再生市场的成长。

预计在预测期内，北美将占据牙科软组织再生市场最大的份额，这主要归因于多种因素。该地区拥有先进的医疗基础设施和较高的医疗支出水平，从而推动了对先进牙科治疗的需求。此外，老年人口的显着增长（老年人易患牙周病）也占北美牙周治疗需求的很大一部分。

有利的政府政策、完善的牙科治疗报销制度以及较高的病患健保覆盖率也进一步促进了人们获得先进牙科护理服务。此外，牙科技术和生物材料的持续研发也推动了该地区市场的扩张。

本报告对全球牙科软组织再生市场进行了分析，按产品类型、应用、最终用户和地区进行了细分，并对参与该市场的公司进行了概况介绍。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章重要考察

第五章 市场概览

  • 介绍
  • 市场动态
  • 产业趋势
  • 价值链分析
  • 技术分析
  • 波特五力分析
  • 主要相关人员和采购标准
  • 监管分析
  • 专利分析
  • 贸易分析
  • 定价分析
  • 2024-2025年重要会议和活动
  • 未满足的需求/最终用户期望
  • 邻近市场分析
  • 生态系分析
  • 案例研究分析
  • 供应链分析
  • 影响客户业务的趋势/颠覆性因素
  • 投资和资金筹措方案
  • 还款方案分析
  • 人工智慧/生成式人工智慧对牙科软组织再生市场的影响
  • 2024年主要地区牙龈疾病盛行率
  • 主要地区手术数（2024 年）
  • 2025年美国关税对牙科软组织再生市场的影响

6. 依产品类型分類的牙科软组织再生市场

  • 介绍
  • 胶原蛋白膜
  • 自体移植
  • 合成生医材料
  • 其他的

第七章 牙科软组织再生市场（依应用领域划分）

  • 介绍
  • 植入
  • 牙周病学
  • 其他的

8. 依最终用户分類的牙科软组织再生市场

  • 介绍
  • 牙医诊所
  • 牙科服务机构及独立诊所
  • 学术研究机构

9. 按地区分類的牙科软组织再生市场

  • 介绍
  • 北美洲
    • 北美宏观经济展望
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲宏观经济展望
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 其他的
  • 亚太地区
    • 亚太宏观经济展望
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 其他的
  • 拉丁美洲
    • 拉丁美洲宏观经济展望
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他的
  • 中东和非洲
    • 政府采取措施发展基础设施以支持市场成长
    • 中东和非洲宏观经济展望
  • 海湾合作委员会国家
    • 可支配收入的增加推动了市场成长
    • 海湾合作委员会国家宏观经济展望

第十章 竞争格局

  • 介绍
  • 主要参与企业的策略/优势
  • 2019-2023年收入分析
  • 2024年市占率分析
  • 公司估值矩阵：主要参与企业，2024 年
  • 公司估值矩阵：Start-Ups/中小企业，2024 年
  • 品牌/产品对比
  • 主要企业的研发支出
  • 估值和财务指标
  • 竞争场景

第十一章：公司简介

  • 主要参与企业
    • GEISTLICH PHARMA AG
    • INSTITUT STRAUMANN AG
    • HENRY SCHEIN, INC.
    • ENVISTA
    • ZIMVIE INC.
    • DENTSPLY SIRONA INC.
    • ABBVIE INC.
    • ADVANCED MEDICAL SOLUTIONS GROUP PLC
    • TISSUE REGENIX
    • SEPTODONT HOLDING
    • MEDICAL CONSULT IMPLANTS GMBH
    • MECCELLIS BIOTECH
    • REGEDENT AG
    • REGENITY
    • AD SURGICAL
  • 其他公司
    • LIFENET HEALTH
    • B. & B. DENTAL SRL
    • ALPHA-BIO TEC. LTD.
    • LASAK SRO
    • KEYSTONE DENTAL GROUP
    • NEOSS AG
    • BEGO GMBH & CO. KG
    • BIOTECH DENTAL
    • SAMYANG HOLDINGS CORPORATION
    • RTI SURGICAL

第十二章附录

Product Code: MD 9222

The dental soft-tissue regeneration market is projected to grow from USD 0.38 billion in 2025 to USD 0.53 billion by 2030, at a CAGR of 6.8% during this period. This market has experienced significant growth due to several factors, including the rising incidence of periodontal diseases, increasing awareness of oral health, and the growing trend of cosmetic dentistry. Furthermore, initiatives to develop healthcare infrastructure in underdeveloped regions are driving the demand for more dental treatments and related products.

Scope of the Report
Years Considered for the Study2024-2030
Base Year2024
Forecast Period2024-2030
Units ConsideredValue (USD billion)
SegmentsProduct Type, Application, End User, and Region
Regions coveredNorth America, Europe, APAC, LATAM, MEA, and GCC countries

Additionally, advancements in regenerative biomaterials have also played a crucial role in the market's expansion.

Dental Soft-tissue Regeneration Market - IMG1

"By product type, the collagen-based membranes segment accounted for the largest share of the dental soft-tissue regeneration market in 2024."

Based on product type, the collagen-based membranes segment is expected to dominate the dental soft-tissue regeneration market due to several factors. Collagen-based membranes act as barriers that guide tissue growth, supporting the healing of periodontal and implant-related defects. Additionally, these membranes can integrate with surrounding tissues and promote the growth of new connective tissue. Furthermore, innovations in regenerative biomaterials are also contributing to the growth of this market.

"By application, the implantology segment accounted for the largest share of the dental soft-tissue regeneration market in 2024."

The implantology segment is expected to hold the largest share of the dental soft-tissue regeneration market due to factors such as the growing aging population, increased awareness of oral health, and rising demand for cosmetic dentistry. Products like collagen membranes, soft-tissue grafts, and advanced bioactive materials are increasingly utilized to promote healing in peri-implant soft tissues. Additionally, innovations in soft-tissue regenerative solutions and heightened awareness of dental aesthetics further contribute to the growth of the dental soft-tissue regeneration market.

"By region, North America accounted for the largest share of the dental soft-tissue regeneration market."

Due to several factors, North America is expected to account for the largest share of the dental soft-tissue regeneration market during the forecast period. The region has advanced healthcare infrastructure and high healthcare expenditure rates, which drive the demand for sophisticated dental care treatments. Additionally, the significant increase in the geriatric population, who are more susceptible to periodontal diseases, accounts for a considerable portion of the treatments needed in North America.

Favorable government policies, reimbursement frameworks for dental care treatments, and high patient insurance coverage further encourage access to advanced dental care. Moreover, ongoing research and development in dental technologies and biomaterials support the expansion of this market in the region.

A breakdown of the primary participants (supply side) for the dental soft-tissue regeneration market referred to in this report is provided below:

  • By Company Type: Tier 1 (35%), Tier 2 (40%), and Tier 3 (25%)
  • By Designation: C-level Executives (45%), Director-level Executives (35%), and Others (20%)
  • By Region: North America (27%), Europe (25%), Asia Pacific (30%), Latin America (8%), and the Middle East & Africa (10%)

Prominent players in the dental soft-tissue regeneration market are Geistlich Pharma AG (Switzerland), DENTSPLY Sirona (US), Institut Straumann AG (Switzerland), Zimvie Inc. (US), Henry Schein, Inc. (US), AbbVie Inc. (US), Advanced Medical Solutions Group Plc (UK), Tissue Regenix (UK), Septodont Holding (France), Medical Consult Implants GmbH (Germany), Meccellis (US), Regedent Ag (Switzerland), Regenity (US), Envista (US), AD Surgical (US), LifeNet Health (US), B. & B. Dental S.R.L. (Italy), Alpha-Bio Tec. Ltd. (Israel), Lasak S.R.O. (Czechia), KeystoneDentalGroup (US), Neoss AG (Switzerland), BEGO GmbH Co. KG (Germany), Biotech Dental (France), Samyang Holdings Corporation (South Korea), and RTI Surgical (US).

Research Coverage:

The report examines the dental soft-tissue regeneration market and seeks to estimate its market size and future growth potential across various segments, including product type, application, end user, and region. Additionally, the report features a competitive analysis of the key players in this market, including their company profiles, service offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report is designed to assist both market leaders and new entrants in the dental soft-tissue regeneration market by providing close estimates of revenue figures. It will help stakeholders understand the competitive landscape, enabling them to better position their businesses and plan effective go-to-market strategies. Additionally, the report offers insights into the current trends in the market, including key drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

  • Analysis of key drivers (rising prevalence of periodontal diseases, rising awareness and growing demand for cosmetic dentistry, advancements in biomaterials, and advancements in regenerative technology), restraints (inadequate reimbursement and high cost of dental services and dearth of trained dental practitioners), opportunities (consolidation of dental practices and rising DSO activity, growing focus on emerging economies and rising disposable income levels, and growing dental tourism in emerging countries), and challenges (pricing pressure faced by prominent market players, and stringent regulatory environment).
  • Market Penetration: It contains comprehensive information on products offered by the key players in the global dental soft-tissue regeneration market. The report covers various segments, including product type, application, end user, and region.
  • Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global dental soft-tissue regeneration market.
  • Market Development: Thorough knowledge and analysis of the profitable rising markets by type, application, end user, and region.
  • Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global dental soft-tissue regeneration market.
  • Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products, and capacities of the major competitors in the global dental soft-tissue regeneration market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 SEGMENTS CONSIDERED & GEOGRAPHICAL SPREAD
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key sources for secondary research
      • 2.1.1.2 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Objectives of primary research
      • 2.1.2.2 Key data from primary sources
      • 2.1.2.3 Key industry insights
      • 2.1.2.4 Breakdown of primaries
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS)
    • 2.2.2 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS
    • 2.2.3 TOP-DOWN APPROACH (SUPPLY-SIDE ANALYSIS)
  • 2.3 DATA TRIANGULATION
  • 2.4 MARKET SHARE ESTIMATION
  • 2.5 STUDY ASSUMPTIONS
  • 2.6 RESEARCH LIMITATIONS
  • 2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 DENTAL SOFT-TISSUE REGENERATION MARKET OVERVIEW
  • 4.2 ASIA PACIFIC: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE AND COUNTRY (2024)
  • 4.3 DENTAL SOFT-TISSUE REGENERATION MARKET: REGIONAL MIX
  • 4.4 DENTAL SOFT-TISSUE REGENERATION MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
  • 4.5 DENTAL SOFT-TISSUE REGENERATION MARKET: EMERGING VS. DEVELOPED MARKETS

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising prevalence of periodontal diseases
      • 5.2.1.2 Growing demand for cosmetic dentistry
      • 5.2.1.3 Rising popularity of biodegradable biomaterials
      • 5.2.1.4 Advancements in regenerative technologies
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Inadequate dental insurance reimbursements and high cost of dental services
      • 5.2.2.2 Dearth of trained dental practitioners
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Introduction of dental service organizations and consolidation of dental practices
      • 5.2.3.2 Growth opportunities in emerging economies
      • 5.2.3.3 Increasing popularity of dental tourism in emerging countries
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Pricing pressure and increased market competition
      • 5.2.4.2 Stringent regulatory environment
  • 5.3 INDUSTRY TRENDS
    • 5.3.1 ADVANCEMENTS IN DIGITAL DENTISTRY
    • 5.3.2 INCREASED NUMBER OF MINIMALLY INVASIVE DENTAL PROCEDURES
  • 5.4 VALUE CHAIN ANALYSIS
  • 5.5 TECHNOLOGY ANALYSIS
    • 5.5.1 KEY TECHNOLOGIES
      • 5.5.1.1 3D bioprinting
    • 5.5.2 COMPLEMENTARY TECHNOLOGIES
      • 5.5.2.1 Laser-assisted technology
    • 5.5.3 ADJACENT TECHNOLOGIES
      • 5.5.3.1 Advanced biomaterials
  • 5.6 PORTER'S FIVE FORCES ANALYSIS
    • 5.6.1 THREAT OF NEW ENTRANTS
    • 5.6.2 THREAT OF SUBSTITUTES
    • 5.6.3 BARGAINING POWER OF SUPPLIERS
    • 5.6.4 BARGAINING POWER OF BUYERS
    • 5.6.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.7 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.7.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.7.2 KEY BUYING CRITERIA
  • 5.8 REGULATORY ANALYSIS
    • 5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.8.2 REGULATORY FRAMEWORK
      • 5.8.2.1 North America
        • 5.8.2.1.1 US
      • 5.8.2.2 Europe
      • 5.8.2.3 Asia Pacific
        • 5.8.2.3.1 India
        • 5.8.2.3.2 China
        • 5.8.2.3.3 Japan
  • 5.9 PATENT ANALYSIS
    • 5.9.1 KEY PATENTS GRANTED
  • 5.10 TRADE ANALYSIS
    • 5.10.1 IMPORT DATA FOR HS CODE 300640
    • 5.10.2 EXPORT DATA FOR HS CODE 300640
  • 5.11 PRICING ANALYSIS
    • 5.11.1 INDICATIVE SELLING PRICE OF DENTAL SOFT-TISSUE REGENERATION PRODUCTS, BY KEY PLAYER, 2022-2024
    • 5.11.2 INDICATIVE SELLING PRICE OF DENTAL SOFT-TISSUE REGENERATION PRODUCTS, BY REGION, 2022-2024
  • 5.12 KEY CONFERENCES & EVENTS, 2024-2025
  • 5.13 UNMET NEEDS/END-USER EXPECTATIONS
  • 5.14 ADJACENT MARKET ANALYSIS
  • 5.15 ECOSYSTEM ANALYSIS
  • 5.16 CASE STUDY ANALYSIS
    • 5.16.1 GUIDED TISSUE REGENERATION BETWEEN NATURAL TOOTH AND IMPLANT WITH OSSIX PLUS
    • 5.16.2 ENAMEL MATRIX DERIVATIVE FOR SOFT-TISSUE REGENERATION
    • 5.16.3 APPLICATION OF HARD- AND SOFT-TISSUE REGENERATIVE APPROACH IN PREDICTABLE MANAGEMENT OF PERI-IMPLANTITIS
  • 5.17 SUPPLY CHAIN ANALYSIS
  • 5.18 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.19 INVESTMENT & FUNDING SCENARIO
  • 5.20 REIMBURSEMENT SCENARIO ANALYSIS
  • 5.21 IMPACT OF AI/GEN AI ON DENTAL SOFT-TISSUE REGENERATION MARKET
  • 5.22 PREVALENCE OF GINGIVAL DISEASES, BY KEY REGION, 2024
  • 5.23 TOTAL NUMBER OF SURGERIES, BY KEY REGION, 2024
  • 5.24 IMPACT OF 2025 US TARIFF ON DENTAL SOFT-TISSUE REGENERATION MARKET
    • 5.24.1 INTRODUCTION
    • 5.24.2 KEY TARIFF RATES
    • 5.24.3 PRICE IMPACT ANALYSIS
    • 5.24.4 IMPACT ON COUNTRY/REGION
      • 5.24.4.1 North America
        • 5.24.4.1.1 US
      • 5.24.4.2 Europe
      • 5.24.4.3 Asia Pacific
    • 5.24.5 IMPACT ON END-USE INDUSTRIES

6 DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE

  • 6.1 INTRODUCTION
  • 6.2 COLLAGEN-BASED MEMBRANES
    • 6.2.1 POTENTIAL TO ENHANCE DENTAL TISSUE REGENERATION TO DRIVE MARKET
  • 6.3 AUTOGRAFTS
    • 6.3.1 HIGH COMPATIBILITY AND REDUCED INFECTION RISKS TO DRIVE MARKET
  • 6.4 SYNTHETIC BIOMATERIALS
    • 6.4.1 TECHNOLOGICAL ADVANCEMENTS IN BIOMATERIALS TO FUEL MARKET GROWTH
  • 6.5 OTHER PRODUCT TYPES

7 DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
  • 7.2 IMPLANTOLOGY
    • 7.2.1 GROWING NEED FOR IMPLANT-SUPPORTED SOFT-TISSUE REGENERATION TO DRIVE MARKET
  • 7.3 PERIODONTOLOGY
    • 7.3.1 INCREASING PREVALENCE OF PERIODONTAL DISEASES TO FAVOR MARKET GROWTH
  • 7.4 OTHER APPLICATIONS

8 DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER

  • 8.1 INTRODUCTION
  • 8.2 DENTAL HOSPITALS
    • 8.2.1 GROWING AWARENESS OF ORAL HEALTH TO BOOST MARKET
  • 8.3 DSOS & INDEPENDENT CLINICS
    • 8.3.1 ADVANCEMENTS IN DENTAL CARE TO DRIVE DEMAND
  • 8.4 ACADEMIC & RESEARCH INSTITUTES
    • 8.4.1 DEVELOPMENT OF ADVANCED DENTAL SOLUTIONS TO BOOST MARKET GROWTH

9 DENTAL SOFT-TISSUE REGENERATION MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    • 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 9.2.2 US
      • 9.2.2.1 US to dominate North American dental soft-tissue regeneration market
    • 9.2.3 CANADA
      • 9.2.3.1 Stringent regulatory compliance to support market growth
  • 9.3 EUROPE
    • 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 9.3.2 GERMANY
      • 9.3.2.1 Germany accounted for the largest share of European dental soft-tissue regeneration market in 2024
    • 9.3.3 UK
      • 9.3.3.1 Rising number of geriatric patients to drive market
    • 9.3.4 FRANCE
      • 9.3.4.1 Well-established healthcare system to drive market
    • 9.3.5 SPAIN
      • 9.3.5.1 Favorable government initiatives for providing dental coverage to support market growth
    • 9.3.6 ITALY
      • 9.3.6.1 Increasing penetration of dental products to drive market growth
    • 9.3.7 REST OF EUROPE
  • 9.4 ASIA PACIFIC
    • 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 9.4.2 JAPAN
      • 9.4.2.1 Rising geriatric population to support market growth
    • 9.4.3 CHINA
      • 9.4.3.1 Growing geriatric population and increasing per capita income to support market growth
    • 9.4.4 INDIA
      • 9.4.4.1 Growing dental care sector to fuel market growth
    • 9.4.5 AUSTRALIA
      • 9.4.5.1 Growing healthcare expenditure to aid market growth
    • 9.4.6 SOUTH KOREA
      • 9.4.6.1 Well-developed healthcare sector to drive market
    • 9.4.7 REST OF ASIA PACIFIC
  • 9.5 LATIN AMERICA
    • 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 9.5.2 BRAZIL
      • 9.5.2.1 Brazil to hold largest share in Latin American market
    • 9.5.3 MEXICO
      • 9.5.3.1 Increasing healthcare infrastructure to propel market growth
    • 9.5.4 ARGENTINA
      • 9.5.4.1 Advancements in dental technology to spur growth
    • 9.5.5 REST OF LATIN AMERICA
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 GOVERNMENT INITIATIVES FOR INFRASTRUCTURAL DEVELOPMENT TO SUPPORT MARKET GROWTH
    • 9.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 9.7 GCC COUNTRIES
    • 9.7.1 RISING DISPOSABLE INCOMES TO DRIVE MARKET GROWTH
    • 9.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES

10 COMPETITIVE LANDSCAPE

  • 10.1 INTRODUCTION
  • 10.2 KEY PLAYER STRATEGY/RIGHT TO WIN
    • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN DENTAL SOFT-TISSUE REGENERATION MARKET
  • 10.3 REVENUE ANALYSIS, 2019-2023
  • 10.4 MARKET SHARE ANALYSIS, 2024
  • 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • 10.5.1 STARS
    • 10.5.2 EMERGING LEADERS
    • 10.5.3 PERVASIVE PLAYERS
    • 10.5.4 PARTICIPANTS
    • 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
      • 10.5.5.1 Company footprint
      • 10.5.5.2 Region footprint
      • 10.5.5.3 Product footprint
      • 10.5.5.4 Application footprint
      • 10.5.5.5 End-user footprint
  • 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    • 10.6.1 PROGRESSIVE COMPANIES
    • 10.6.2 RESPONSIVE COMPANIES
    • 10.6.3 DYNAMIC COMPANIES
    • 10.6.4 STARTING BLOCKS
    • 10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
      • 10.6.5.1 Detailed list of key startups/SMEs
      • 10.6.5.2 Competitive benchmarking of startups/SMEs, by product type
      • 10.6.5.3 Competitive benchmarking of startups/SMEs, by region
  • 10.7 BRAND/PRODUCT COMPARISON
  • 10.8 R&D EXPENDITURE OF KEY PLAYERS
  • 10.9 COMPANY VALUATION & FINANCIAL METRICS
    • 10.9.1 FINANCIAL METRICS
    • 10.9.2 COMPANY VALUATION
  • 10.10 COMPETITIVE SCENARIO
    • 10.10.1 PRODUCT LAUNCHES
    • 10.10.2 DEALS
    • 10.10.3 EXPANSIONS

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS
    • 11.1.1 GEISTLICH PHARMA AG
      • 11.1.1.1 Business overview
      • 11.1.1.2 Products offered
      • 11.1.1.3 Recent developments
        • 11.1.1.3.1 Deals
        • 11.1.1.3.2 Expansions
      • 11.1.1.4 MnM view
        • 11.1.1.4.1 Right to win
        • 11.1.1.4.2 Strategic choices
        • 11.1.1.4.3 Weaknesses & competitive threats
    • 11.1.2 INSTITUT STRAUMANN AG
      • 11.1.2.1 Business overview
      • 11.1.2.2 Products offered
      • 11.1.2.3 MnM view
        • 11.1.2.3.1 Right to win
        • 11.1.2.3.2 Strategic choices
        • 11.1.2.3.3 Weaknesses & competitive threats
    • 11.1.3 HENRY SCHEIN, INC.
      • 11.1.3.1 Business overview
      • 11.1.3.2 Products offered
      • 11.1.3.3 Recent developments
        • 11.1.3.3.1 Deals
      • 11.1.3.4 MnM view
        • 11.1.3.4.1 Right to win
        • 11.1.3.4.2 Strategic choices
        • 11.1.3.4.3 Weaknesses & competitive threats
    • 11.1.4 ENVISTA
      • 11.1.4.1 Business overview
      • 11.1.4.2 Products offered
      • 11.1.4.3 Recent developments
        • 11.1.4.3.1 Deals
      • 11.1.4.4 MnM view
        • 11.1.4.4.1 Right to win
        • 11.1.4.4.2 Strategic choices
        • 11.1.4.4.3 Weaknesses & competitive threats
    • 11.1.5 ZIMVIE INC.
      • 11.1.5.1 Business overview
      • 11.1.5.2 Products offered
      • 11.1.5.3 Recent developments
        • 11.1.5.3.1 Deals
      • 11.1.5.4 MnM view
        • 11.1.5.4.1 Right to win
        • 11.1.5.4.2 Strategic choices
        • 11.1.5.4.3 Weaknesses & competitive threats
    • 11.1.6 DENTSPLY SIRONA INC.
      • 11.1.6.1 Business overview
      • 11.1.6.2 Products offered
      • 11.1.6.3 Recent developments
        • 11.1.6.3.1 Product launches
        • 11.1.6.3.2 Deals
    • 11.1.7 ABBVIE INC.
      • 11.1.7.1 Business overview
      • 11.1.7.2 Products offered
      • 11.1.7.3 Recent developments
        • 11.1.7.3.1 Expansions
    • 11.1.8 ADVANCED MEDICAL SOLUTIONS GROUP PLC
      • 11.1.8.1 Business overview
      • 11.1.8.2 Products offered
      • 11.1.8.3 Recent developments
        • 11.1.8.3.1 Deals
    • 11.1.9 TISSUE REGENIX
      • 11.1.9.1 Business overview
      • 11.1.9.2 Products offered
    • 11.1.10 SEPTODONT HOLDING
      • 11.1.10.1 Business overview
      • 11.1.10.2 Products offered
      • 11.1.10.3 Recent developments
        • 11.1.10.3.1 Deals
    • 11.1.11 MEDICAL CONSULT IMPLANTS GMBH
      • 11.1.11.1 Business overview
      • 11.1.11.2 Products offered
    • 11.1.12 MECCELLIS BIOTECH
      • 11.1.12.1 Business overview
      • 11.1.12.2 Products offered
    • 11.1.13 REGEDENT AG
      • 11.1.13.1 Business overview
      • 11.1.13.2 Products offered
    • 11.1.14 REGENITY
      • 11.1.14.1 Business overview
      • 11.1.14.2 Products offered
      • 11.1.14.3 Recent developments
        • 11.1.14.3.1 Deals
    • 11.1.15 AD SURGICAL
      • 11.1.15.1 Business overview
      • 11.1.15.2 Products offered
  • 11.2 OTHER PLAYERS
    • 11.2.1 LIFENET HEALTH
    • 11.2.2 B. & B. DENTAL S.R.L.
    • 11.2.3 ALPHA-BIO TEC. LTD.
    • 11.2.4 LASAK S.R.O.
    • 11.2.5 KEYSTONE DENTAL GROUP
    • 11.2.6 NEOSS AG
    • 11.2.7 BEGO GMBH & CO. KG
    • 11.2.8 BIOTECH DENTAL
    • 11.2.9 SAMYANG HOLDINGS CORPORATION
    • 11.2.10 RTI SURGICAL

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 DENTAL SOFT-TISSUE REGENERATION MARKET: INCLUSIONS & EXCLUSIONS
  • TABLE 2 STANDARD CURRENCY CONVERSION RATES (USD), 2019-2023
  • TABLE 3 DENTAL SOFT-TISSUE REGENERATION MARKET: RISK ANALYSIS
  • TABLE 4 US: AVERAGE SPENDING BY PATIENTS ON COSMETIC DENTISTRY, 2021 VS. 2022
  • TABLE 5 DENTAL SOFT-TISSUE REGENERATION MARKET: PORTER'S FIVE FORCES
  • TABLE 6 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS
  • TABLE 7 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
  • TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 DENTAL SOFT-TISSUE REGENERATION MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2022-2024
  • TABLE 14 IMPORT DATA FOR HS CODE 300640, BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 15 EXPORT DATA FOR HS CODE 300640, BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 16 INDICATIVE SELLING PRICE OF DENTAL SOFT-TISSUE REGENERATION PRODUCTS, BY KEY PLAYER, 2022-2024 (USD)
  • TABLE 17 INDICATIVE SELLING PRICE OF DENTAL SOFT-TISSUE REGENERATION PRODUCTS, BY REGION, 2022-2024 (USD)
  • TABLE 18 DENTAL SOFT-TISSUE REGENERATION MARKET: KEY CONFERENCES & EVENTS, JANUARY 2024-DECEMBER 2025
  • TABLE 19 DENTAL SOFT-TISSUE REGENERATION MARKET: UNMET NEEDS/END-USER EXPECTATIONS
  • TABLE 20 DENTAL SOFT-TISSUE REGENERATION MARKET: ROLE IN ECOSYSTEM
  • TABLE 21 CASE STUDY 1: GUIDED TISSUE REGENERATION BETWEEN NATURAL TOOTH AND IMPLANT WITH OSSIX PLUS
  • TABLE 22 CASE STUDY 2: ENAMEL MATRIX DERIVATIVE FOR SOFT-TISSUE REGENERATION
  • TABLE 23 CASE STUDY 3: APPLICATION OF HARD- AND SOFT-TISSUE REGENERATIVE APPROACH IN PREDICTABLE MANAGEMENT OF PERI-IMPLANTITIS
  • TABLE 24 PREVALENCE OF GINGIVAL DISEASES BY KEY REGION 2024
  • TABLE 25 TOTAL NUMBER OF SURGERIES BY KEY REGION 2024
  • TABLE 26 US ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 27 KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR DENTAL SOFT-TISSUE REGENERATION
  • TABLE 28 DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 29 DENTAL SOFT-TISSUE REGENERATION MARKET FOR COLLAGEN-BASED MEMBRANES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 30 DENTAL SOFT-TISSUE REGENERATION MARKET FOR AUTOGRAFTS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 31 DENTAL SOFT-TISSUE REGENERATION MARKET FOR SYNTHETIC BIOMATERIALS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 32 DENTAL SOFT-TISSUE REGENERATION MARKET FOR OTHER PRODUCT TYPES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 33 DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 34 DENTAL SOFT-TISSUE REGENERATION MARKET FOR IMPLANTOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 35 DENTAL SOFT-TISSUE REGENERATION MARKET FOR PERIODONTOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 36 DENTAL SOFT-TISSUE REGENERATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 37 DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 38 DENTAL SOFT-TISSUE REGENERATION MARKET FOR DENTAL HOSPITALS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 39 DENTAL SOFT-TISSUE REGENERATION FOR DSOS & INDEPENDENT CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 40 DENTAL SOFT-TISSUE REGENERATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 41 DENTAL SOFT-TISSUE REGENERATION MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 42 NORTH AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 43 NORTH AMERICA, DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 44 NORTH AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 45 NORTH AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 46 US: KEY MACROINDICATORS
  • TABLE 47 US: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 48 US: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 49 US: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 50 CANADA: KEY MACROINDICATORS
  • TABLE 51 CANADA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 52 CANADA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 53 CANADA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 54 EUROPE DENTAL SOFT-TISSUE REGENERATION MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 55 EUROPE: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 56 EUROPE: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 57 EUROPE: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 58 GERMANY: KEY MACROINDICATORS
  • TABLE 59 GERMANY: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 60 GERMANY: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 61 GERMANY: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 62 UK: KEY MACROINDICATORS
  • TABLE 63 UK: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 64 UK: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 65 UK: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 66 FRANCE: KEY MACROINDICATORS
  • TABLE 67 FRANCE: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 68 FRANCE: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 69 FRANCE: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 70 SPAIN: KEY MACROINDICATORS
  • TABLE 71 SPAIN: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 72 SPAIN: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 73 SPAIN: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 74 ITALY: KEY MACROINDICATORS
  • TABLE 75 ITALY: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 76 ITALY: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 77 ITALY: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 78 REST OF EUROPE: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 79 REST OF EUROPE: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 80 REST OF EUROPE: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 81 ASIA PACIFIC DENTAL SOFT-TISSUE REGENERATION MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 82 ASIA PACIFIC: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 83 ASIA PACIFIC: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 84 ASIA PACIFIC: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 85 JAPAN: KEY MACROINDICATORS
  • TABLE 86 JAPAN: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 87 JAPAN: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 88 JAPAN: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 89 CHINA: KEY MACROINDICATORS
  • TABLE 90 CHINA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 91 CHINA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 92 CHINA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 93 INDIA: KEY MACROINDICATORS
  • TABLE 94 INDIA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 95 INDIA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 96 INDIA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 97 AUSTRALIA: KEY MACROINDICATORS
  • TABLE 98 AUSTRALIA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 99 AUSTRALIA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 100 AUSTRALIA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 101 SOUTH KOREA: KEY MACROINDICATORS
  • TABLE 102 SOUTH KOREA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 103 SOUTH KOREA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 104 SOUTH KOREA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 105 REST OF ASIA PACIFIC: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 106 REST OF ASIA PACIFIC: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 107 REST OF ASIA PACIFIC: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 108 LATIN AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 109 LATIN AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 110 LATIN AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 111 LATIN AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 112 BRAZIL: KEY MACROINDICATORS
  • TABLE 113 BRAZIL: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 114 BRAZIL: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 115 BRAZIL: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 116 MEXICO: KEY MACROINDICATORS
  • TABLE 117 MEXICO: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 118 MEXICO: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 119 MEXICO: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 120 ARGENTINA: KEY MACROINDICATORS
  • TABLE 121 ARGENTINA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 122 ARGENTINA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 123 ARGENTINA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 124 REST OF LATIN AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 125 REST OF LATIN AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 126 REST OF LATIN AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 127 MIDDLE EAST & AFRICA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 128 MIDDLE EAST & AFRICA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 129 MIDDLE EAST & AFRICA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 130 GCC COUNTRIES: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 131 GCC COUNTRIES: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 132 GCC COUNTRIES: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 133 DENTAL SOFT-TISSUE REGENERATION MARKET: DEGREE OF COMPETITION
  • TABLE 134 DENTAL SOFT-TISSUE REGENERATION MARKET: REGION FOOTPRINT
  • TABLE 135 DENTAL SOFT-TISSUE REGENERATION MARKET: PRODUCT FOOTPRINT
  • TABLE 136 DENTAL SOFT-TISSUE REGENERATION MARKET: APPLICATION FOOTPRINT
  • TABLE 137 DENTAL SOFT-TISSUE REGENERATION MARKET: END-USER FOOTPRINT
  • TABLE 138 DENTAL SOFT-TISSUE REGENERATION MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 139 DENTAL SOFT-TISSUE REGENERATION MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES, BY PRODUCT TYPE
  • TABLE 140 DENTAL SOFT-TISSUE REGENERATION MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES, BY REGION
  • TABLE 141 DENTAL SOFT-TISSUE REGENERATION MARKET: PRODUCT LAUNCHES, JANUARY 2021-MARCH 2025
  • TABLE 142 DENTAL SOFT-TISSUE REGENERATION MARKET: DEALS, JANUARY 2021-MARCH 2025
  • TABLE 143 DENTAL SOFT-TISSUE REGENERATION MARKET: EXPANSIONS, JANUARY 2021-MARCH 2025
  • TABLE 144 GEISTLICH PHARMA AG: COMPANY OVERVIEW
  • TABLE 145 GEISTLICH PHARMA AG: PRODUCTS OFFERED
  • TABLE 146 GEISTLICH PHARMA AG: DEALS, JANUARY 2021-MARCH 2025
  • TABLE 147 GEISTLICH PHARMA AG: EXPANSIONS, JANUARY 2021-MARCH 2025
  • TABLE 148 INSTITUT STRAUMANN AG: COMPANY OVERVIEW
  • TABLE 149 INSTITUT STRAUMANN AG: PRODUCTS OFFERED
  • TABLE 150 HENRY SCHEIN, INC.: COMPANY OVERVIEW
  • TABLE 151 HENRY SCHEIN, INC.: PRODUCTS OFFERED
  • TABLE 152 HENRY SCHEIN, INC.: DEALS, JANUARY 2021-MARCH 2025
  • TABLE 153 ENVISTA: COMPANY OVERVIEW
  • TABLE 154 ENVISTA: PRODUCTS OFFERED
  • TABLE 155 ENVISTA: DEALS, JANUARY 2021-MARCH 2025
  • TABLE 156 ZIMVIE INC.: COMPANY OVERVIEW
  • TABLE 157 ZIMVIE INC.: PRODUCTS OFFERED
  • TABLE 158 ZIMVIE INC.: DEALS, JANUARY 2021-MARCH 2025
  • TABLE 159 DENTSPLY SIRONA INC.: COMPANY OVERVIEW
  • TABLE 160 DENTSPLY SIRONA INC.: PRODUCTS OFFERED
  • TABLE 161 DENTSPLY SIRONA INC.: PRODUCT LAUNCHES, JANUARY 2021-MARCH 2025
  • TABLE 162 DENTSPLY SIRONA INC.: DEALS, JANUARY 2021-MARCH 2025
  • TABLE 163 ABBVIE INC.: COMPANY OVERVIEW
  • TABLE 164 ABBVIE INC.: PRODUCTS OFFERED
  • TABLE 165 ABBVIE INC.: EXPANSIONS, JANUARY 2021-MARCH 2025
  • TABLE 166 ADVANCED MEDICAL SOLUTIONS GROUP PLC: COMPANY OVERVIEW
  • TABLE 167 ADVANCED MEDICAL SOLUTIONS GROUP PLC: PRODUCTS OFFERED
  • TABLE 168 ADVANCED MEDICAL SOLUTIONS GROUP PLC: DEALS, JANUARY 2021-MARCH 2025
  • TABLE 169 TISSUE REGENIX: COMPANY OVERVIEW
  • TABLE 170 TISSUE REGENIX: PRODUCTS OFFERED
  • TABLE 171 SEPTODONT HOLDING: COMPANY OVERVIEW
  • TABLE 172 SEPTODONT HOLDING: PRODUCTS OFFERED
  • TABLE 173 SEPTODONT HOLDING: DEALS, JANUARY 2021-MARCH 2025
  • TABLE 174 MEDICAL CONSULT IMPLANTS GMBH: COMPANY OVERVIEW
  • TABLE 175 MEDICAL CONSULT IMPLANTS GMBH: PRODUCTS OFFERED
  • TABLE 176 MECCELLIS BIOTECH: COMPANY OVERVIEW
  • TABLE 177 MECCELLIS BIOTECH: PRODUCTS OFFERED
  • TABLE 178 REGEDENT AG: COMPANY OVERVIEW
  • TABLE 179 REGEDENT AG: PRODUCTS OFFERED
  • TABLE 180 REGENITY: COMPANY OVERVIEW
  • TABLE 181 REGENITY: PRODUCTS OFFERED
  • TABLE 182 REGENITY: DEALS, JANUARY 2021-MARCH 2025
  • TABLE 183 AD SURGICAL: COMPANY OVERVIEW
  • TABLE 184 AD SURGICAL: PRODUCTS OFFERED
  • TABLE 185 LIFENET HEALTH: COMPANY OVERVIEW
  • TABLE 186 B. & B. DENTAL S.R.L.: COMPANY OVERVIEW
  • TABLE 187 ALPHA-BIO TEC. LTD.: COMPANY OVERVIEW
  • TABLE 188 LASAK S.R.O.: COMPANY OVERVIEW
  • TABLE 189 KEYSTONE DENTAL GROUP: COMPANY OVERVIEW
  • TABLE 190 NEOSS AG: COMPANY OVERVIEW
  • TABLE 191 BEGO GMBH & CO. KG: COMPANY OVERVIEW
  • TABLE 192 BIOTECH DENTAL: COMPANY OVERVIEW
  • TABLE 193 SAMYANG HOLDINGS CORPORATION: COMPANY OVERVIEW
  • TABLE 194 RTI SURGICAL: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 DENTAL SOFT-TISSUE REGENERATION MARKET: SEGMENTS CONSIDERED & GEOGRAPHICAL SPREAD
  • FIGURE 2 DENTAL SOFT-TISSUE REGENERATION MARKET: YEARS CONSIDERED
  • FIGURE 3 DENTAL SOFT-TISSUE REGENERATION MARKET: RESEARCH DESIGN
  • FIGURE 4 DENTAL SOFT-TISSUE REGENERATION MARKET: KEY DATA FROM SECONDARY SOURCES
  • FIGURE 5 DENTAL SOFT-TISSUE REGENERATION MARKET: KEY PRIMARY SOURCES
  • FIGURE 6 DENTAL SOFT-TISSUE REGENERATION MARKET: KEY DATA FROM PRIMARY SOURCES
  • FIGURE 7 DENTAL SOFT-TISSUE REGENERATION MARKET: KEY INDUSTRY INSIGHTS
  • FIGURE 8 BREAKDOWN OF PRIMARIES: SUPPLY- AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 9 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 10 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
  • FIGURE 11 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 12 REVENUE SHARE ANALYSIS ILLUSTRATION FOR INSTITUT STRAUMANN AG (2024)
  • FIGURE 13 SUPPLY-SIDE MARKET SIZE ESTIMATION: DENTAL SOFT-TISSUE REGENERATION MARKET (2023)
  • FIGURE 14 DENTAL SOFT-TISSUE REGENERATION MARKET: TOP-DOWN APPROACH
  • FIGURE 15 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2025-2030)
  • FIGURE 16 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 17 DENTAL SOFT-TISSUE REGENERATION MARKET: DATA TRIANGULATION
  • FIGURE 18 DENTAL SOFT-TISSUE REGENERATION MARKET: STUDY ASSUMPTIONS
  • FIGURE 19 DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 20 DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 21 DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 22 DENTAL SOFT-TISSUE REGENERATION MARKET: REGIONAL SNAPSHOT
  • FIGURE 23 RISING PREVALENCE OF PERIODONTAL DISEASES AND GROWING FOCUS ON DENTAL TOURISM IN EMERGING ECONOMIES TO DRIVE MARKET
  • FIGURE 24 REST OF ASIA PACIFIC AND COLLAGEN-BASED MEMBRANES COMMANDED LARGEST MARKET SHARE IN 2024
  • FIGURE 25 ASIA PACIFIC TO DOMINATE MARKET FROM 2025 TO 2030
  • FIGURE 26 CHINA TO GROW AT HIGHEST CAGR DURING STUDY PERIOD
  • FIGURE 27 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
  • FIGURE 28 DENTAL SOFT-TISSUE REGENERATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 29 DENTAL SOFT-TISSUE REGENERATION MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 30 DENTAL SOFT-TISSUE REGENERATION MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS
  • FIGURE 32 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
  • FIGURE 33 NUMBER OF PATENT PUBLISHED (JANUARY 2014-NOVEMBER 2024)
  • FIGURE 34 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR DENTAL SOFT-TISSUE REGENERATION (JANUARY 2014- NOVEMBER 2024)
  • FIGURE 35 TOP PATENT APPLICANTS, BY JURISDICTION, JANUARY 2014-NOVEMBER 2024
  • FIGURE 36 DENTAL SOFT-TISSUE REGENERATION MARKET: ADJACENT MARKETS
  • FIGURE 37 DENTAL SOFT-TISSUE REGENERATION MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 38 DENTAL SOFT-TISSUE REGENERATION MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 39 DENTAL SOFT-TISSUE REGENERATION MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 40 DENTAL SOFT-TISSUE REGENERATION MARKET: FUNDING AND NUMBER OF DEALS, 2020-2023
  • FIGURE 41 DENTAL SOFT-TISSUE REGENERATION MARKET: IMPACT OF AI/GEN AI
  • FIGURE 42 DENTAL SOFT-TISSUE REGENERATION MARKET: GEOGRAPHIC SNAPSHOT
  • FIGURE 43 NORTH AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET SNAPSHOT
  • FIGURE 44 EUROPE: DENTAL SOFT-TISSUE REGENERATION MARKET SNAPSHOT
  • FIGURE 45 ASIA PACIFIC: DENTAL SOFT-TISSUE REGENERATION MARKET SNAPSHOT
  • FIGURE 46 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN DENTAL SOFT-TISSUE REGENERATION MARKET
  • FIGURE 47 REVENUE ANALYSIS OF KEY PLAYERS IN DENTAL SOFT-TISSUE REGENERATION MARKET (2019-2023)
  • FIGURE 48 MARKET SHARE ANALYSIS OF KEY PLAYERS IN DENTAL SOFT-TISSUE REGENERATION MARKET (2024)
  • FIGURE 49 DENTAL SOFT-TISSUE REGENERATION MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 50 DENTAL SOFT-TISSUE REGENERATION MARKET: COMPANY FOOTPRINT
  • FIGURE 51 DENTAL SOFT-TISSUE REGENERATION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 52 DENTAL SOFT-TISSUE REGENERATION MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 53 R&D EXPENDITURE OF KEY PLAYERS, 2022 VS. 2023
  • FIGURE 54 EV/EBITDA OF KEY VENDORS
  • FIGURE 55 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 56 INSTITUT STRAUMANN AG: COMPANY SNAPSHOT
  • FIGURE 57 HENRY SCHEIN, INC.: COMPANY SNAPSHOT
  • FIGURE 58 ENVISTA: COMPANY SNAPSHOT
  • FIGURE 59 ZIMVIE INC.: COMPANY SNAPSHOT
  • FIGURE 60 DENTSPLY SIRONA INC.: COMPANY SNAPSHOT
  • FIGURE 61 ABBVIE INC.: COMPANY SNAPSHOT
  • FIGURE 62 ADVANCED MEDICAL SOLUTIONS GROUP PLC: COMPANY SNAPSHOT
  • FIGURE 63 TISSUE REGENIX: COMPANY SNAPSHOT